🧬 David Li - Meliora Therapeutics - Part 2 | From Finance to Biotech Entrepreneurship | Building Solid Teams & Navigating Market Dynamics

As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.

Part 2 of 4.

My guest for this week’s episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving cancer therapies using cutting-edge science and machine learning. The company derives a comprehensive picture of how drugs interact with cancer biology by combining biofunctional readouts from numerous modalities using advanced machine learning and other computational techniques.

Before Meliora, David served as Chief Business Officer at Everest Detection, an early detection liquid biopsy startup, and was head of commercial operations at Benchling, a life sciences software platform company which has achieved a $6 billion valuation and has attracted over $500 million in funding.

David began his career in Goldman Sachs Healthcare Investment Banking Group and KKR's Private Equity Group, where he advised and invested in transactions worth over $10 billion in enterprise value. His multifaceted experiences in the financial and life science sectors give him a wide range of experiences that founders can learn from.

Join us this week and hear about:

David’s pivot from finance roles at Goldman Sachs and KKR to early-stage entrepreneurship in the Life Sciences
The challenges of moving from private equity to startups
Aligning personal values with career choices, building solid teams, and the role of luck in success.
His time at Benchling as Head of Commercial Operations and at Everest Detection as the Chief Business Officer

Please enjoy my conversation with David Li.

Timestamps:

00:28 Intro

01:56 Working in Finance at Goldman Sachs and KKR, rethinking how to make an impact

04:59 Switching to early-stage entrepreneurship, prioritizing team strength and market dynamics

06:25 Experience at Benchling, data software issues & digitization in the life sciences

11:09 The role of luck in success, figuring out what you can and can’t control

14:02 Challenges and lessons working in startups, maintaining internal conviction

17:43 Contemplating a new role after Benchling, joining Everest Detection

20:25 The different skills David learned while building a team, getting wins early on

23:56 Outro

Find Our Guest, David Li, at these links: